BORIANI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 23.297
EU - Europa 20.037
AS - Asia 19.842
SA - Sud America 1.269
AF - Africa 1.081
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 11
Totale 65.565
Nazione #
US - Stati Uniti d'America 23.137
VN - Vietnam 6.267
GB - Regno Unito 5.309
SG - Singapore 5.137
CN - Cina 4.626
IT - Italia 3.154
DE - Germania 2.889
UA - Ucraina 1.939
FR - Francia 1.450
HK - Hong Kong 1.335
NL - Olanda 1.227
SE - Svezia 1.194
RU - Federazione Russa 1.141
IN - India 1.104
BR - Brasile 946
IE - Irlanda 580
EE - Estonia 446
JP - Giappone 408
ZA - Sudafrica 398
CI - Costa d'Avorio 239
FI - Finlandia 236
SC - Seychelles 173
KR - Corea 157
AR - Argentina 142
TG - Togo 119
PH - Filippine 106
CA - Canada 88
BD - Bangladesh 82
CH - Svizzera 75
TH - Thailandia 75
IQ - Iraq 70
BG - Bulgaria 69
JO - Giordania 58
BE - Belgio 56
ID - Indonesia 52
MX - Messico 50
TR - Turchia 50
AT - Austria 49
EC - Ecuador 48
GR - Grecia 47
NG - Nigeria 47
PL - Polonia 46
PK - Pakistan 43
TW - Taiwan 39
IR - Iran 38
UZ - Uzbekistan 36
SA - Arabia Saudita 34
CL - Cile 33
CO - Colombia 28
LB - Libano 28
PY - Paraguay 28
EG - Egitto 24
ES - Italia 24
AU - Australia 19
MY - Malesia 19
MA - Marocco 18
RO - Romania 18
CZ - Repubblica Ceca 16
HR - Croazia 15
PE - Perù 13
UY - Uruguay 13
VE - Venezuela 13
KE - Kenya 12
NP - Nepal 11
OM - Oman 11
DZ - Algeria 10
SN - Senegal 10
TN - Tunisia 10
KZ - Kazakistan 9
ET - Etiopia 8
AZ - Azerbaigian 7
EU - Europa 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
NO - Norvegia 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
KG - Kirghizistan 4
LU - Lussemburgo 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
LT - Lituania 3
MD - Moldavia 3
MU - Mauritius 3
QA - Qatar 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
Totale 65.525
Città #
Southend 4.731
Singapore 3.445
Fairfield 2.538
Ashburn 2.024
San Jose 1.538
Jacksonville 1.379
Ho Chi Minh City 1.327
Wilmington 1.283
Hong Kong 1.264
Woodbridge 1.166
Seattle 1.144
Princeton 1.112
Chandler 1.098
Houston 1.072
Hanoi 1.014
Cambridge 869
Santa Clara 803
Dong Ket 788
Ann Arbor 659
Kerkrade 652
Boardman 598
Dublin 579
Lauterbourg 553
Westminster 506
Padova 505
Nanjing 491
Beijing 430
Frankfurt am Main 419
Tokyo 373
Los Angeles 353
Hefei 342
Eygelshoven 338
Berlin 308
Medford 255
Milan 255
Saint Petersburg 254
Jinan 243
Abidjan 239
Shenyang 230
Helsinki 220
Buffalo 215
Mülheim 215
San Diego 188
Changsha 181
Bologna 177
Mahé 160
Hebei 157
Da Nang 153
Nanchang 149
Rome 147
Haiphong 136
New York 135
Dallas 130
Bremen 122
Lomé 119
Redondo Beach 119
Turin 118
Guangzhou 110
Tianjin 110
Seoul 107
Jiaxing 102
São Paulo 95
Shanghai 89
Olalla 88
Des Moines 87
Hangzhou 85
Verona 82
Zhengzhou 80
Yubileyny 78
Norwalk 74
The Dalles 73
Council Bluffs 70
Ningbo 67
Dearborn 66
Biên Hòa 64
Sofia 63
Hải Dương 59
Munich 59
Falls Church 58
Haikou 58
Amman 56
Brussels 52
Can Tho 52
Ninh Bình 52
Chicago 51
Thái Nguyên 51
Ha Long 49
Mountain View 48
London 47
Florence 46
Quận Bình Thạnh 44
San Venanzo 44
Nuremberg 43
Taizhou 43
Abeokuta 42
Lanzhou 42
Bengaluru 40
Bern 40
Phoenix 40
Vũng Tàu 39
Totale 42.763
Nome #
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 1.690
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.084
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 327
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation 316
Incidenza e fattori predittivi di fibrillazione atriale post operatoria nei riceventi di trapianto renale 301
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 298
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) 288
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 286
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 266
Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. A prospective randomized evaluation of VV delay optimization in CRT-D recipients:echocardiographic observations from the RHYTHM II ICD study. 258
Effects of cardiac resynchronization therapy on coronary blood flow: evaluation by transthoracic Doppler echocardiography. Poster European Congress of Cardiology 2007 253
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 249
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 246
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 245
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 245
Atrial fibrillation: it is better to be alone than in bad company! 230
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 228
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 226
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 221
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 216
Aritimie cardiache, morte cardiaca improvvisa, sincope 216
AF burden is important - Fact or fiction? 214
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 207
The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus β-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker 206
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 204
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 204
La tachicardiomiopatia: una revisione della letteratura 203
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 200
Electrocardiographic remodeling during cardiac resynchronization therapy 198
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 197
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 196
Automatic verification of ventricular stimulation: fusion management algorithm 195
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 195
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 195
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 195
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 194
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 193
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 193
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 189
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients. 189
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 189
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 187
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 185
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 185
Atrial fibrillation ablation: beyond electro-mechanical matters 184
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 182
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 182
Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure. 181
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 180
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 179
Automatic management of left ventricular stimulation: hints for technologic improvement. 179
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 178
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 178
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 177
Implantation of cardioverter-defibrillator: Effects on shoulder function. 176
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 174
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 173
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 173
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 173
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 173
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 172
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 172
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 172
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 171
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 171
Rate control in AFFIRM: considerations about the clinical implications. 170
Solution to a crushing dosage problem? 170
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 170
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 170
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 168
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 168
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 166
Can we improve risk stratification for thromboembolic events in atrial fibirillation by combining arrhythmia presence and duration with CHADS2 score? Poster European Congress of Cardiology 2008 166
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 166
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 166
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 165
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 165
The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. 165
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 165
Heart failure after myocardial revascularization: Risk markers. 164
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 164
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 164
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 163
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 162
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 162
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 162
Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke 161
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. 159
Resolution of atrial thrombosis with heparin in a newborn with atrial flutter 159
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. 159
Confronto fra impedenziometria transtoracica ed ecocardiografia doppler nell'ottimizzazione della programmazione dell'intervallo ventricolo-ventricolare. 158
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 158
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 157
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 156
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 156
Self-reported physical activity and major adverse events in patients with atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 156
A randomised comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from bradycardia and atrial fibrillation and implanted with a DDDRP device 155
Atrial fibrillation and heart failure: does one epidemic feed he other? 155
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device. 154
Totale 21.599
Categoria #
all - tutte 164.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.047 0 0 0 0 0 0 0 0 0 392 335 2.320
2021/20227.490 672 377 511 628 774 554 146 603 236 254 1.164 1.571
2022/20236.922 851 887 354 956 380 378 212 349 1.139 335 655 426
2023/20241.655 136 286 114 122 176 276 120 88 82 108 57 90
2024/20257.529 241 1.806 622 643 1.395 391 433 132 72 287 144 1.363
2025/202618.135 2.065 1.500 1.905 1.274 1.782 2.106 2.123 1.442 2.921 1.017 0 0
Totale 66.358